Funding

Switzerland Based Polares Medical Raises $50M Funding In Series C Round

Mar 5, 2026 | By Kailee Rainse

Polares Medical, a clinical-stage structural heart company based in Lausanne, Switzerland, has raised $50 million in a Series C funding round.

SUMMARY

Polares Medical, a clinical-stage structural heart company based in Lausanne, Switzerland, has raised $50 million in a Series C funding round.

The round was backed by DC Global Ventures, Lumination Partners, existing investors, and a new strategic investor.

The company will use the proceeds to expand operations and advance its research and development activities.

RECOMMENDED FOR YOU

News

Private Market Investment Platform Crowdcube has Acquired Semper

Team SR

Nov 6, 2023

Funding

FOSSA Systems funding news – Space Tech Startup FOSSA Systems Secures €6.3 Million in Series A Round Funding

Team SR

Jun 19, 2024

Funding

Irish AI platform Oraion Secures €2.9 Million In Pre-Seed Round To Fuel US Expansion

Kailee Rainse

Jul 10, 2025

Led by CEO Jacques R. Essinger, Polares Medical is developing the MRace Posterior Leaflet Replacement system, a transcatheter therapy designed to treat patients with mitral regurgitation.

“We believe Posterior Leaflet Replacement represents a new chapter in transcatheter mitral therapy,” said Jacques R. Essinger, Ph.D., Chief Executive Officer of Polares Medical. “With over 70 patients of clinical experience and encouraging one-year data demonstrating sustained safety and efficacy, we have established a strong foundation for MRace. This financing positions us to advance the treatment paradigm for complex mitral regurgitation.”

About Polares Medical

Polares Medical SA is a clinical-stage structural heart company developing the MRace Posterior Leaflet Replacement system, a novel transcatheter therapy designed to treat patients suffering from mitral regurgitation.